Sort   by:  
 Page size 
UnknownIdelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Not available
S-EPMC5589180 | biostudies-literature
UnknownA randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstrom macroglobulinemia: the ASPEN study.
Not available
S-EPMC7596850 | biostudies-literature
UnknownPooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies.
Not available
S-EPMC8864647 | biostudies-literature
UnknownPolatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
Not available
S-EPMC11702892 | biostudies-literature
UnknownBiomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenstrom macroglobulinemia.
Not available
S-EPMC11006814 | biostudies-literature
Sort   by:  
 Page size